Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance study-Reference-Cited by-同舟云学术

Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance study

Published:2020-11-03 Issue:11 Volume:15 Page:e0241575
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Iannone Luigi Francesco,Bennardo Luigi,Palleria Caterina,Roberti Roberta,De Sarro Caterina,Naturale Maria Diana,Dastoli Stefano,Donato Luca,Manti Antonia,Valenti Giancarlo,D’Amico Domenico,D’Attola Santo,De Francesco Adele Emanuela,Bosco Vincenzo,Donato Di Paola Eugenio,Nisticò Steven Paul,Citraro Rita,Russo Emilio,De Sarro Giovambattista

Funder

Agenzia Italiana del Farmaco, Ministero della Salute

Regione Calabria

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference28 articles.

1. Psoriasis;W-H Boehncke;Lancet,2015

2. Psoriasis;FO Nestle;N Engl J Med,2009

3. Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis;E Daudén;J Eur Acad Dermatology Venereol,2013

4. European S3-Guideline on the systemic treatment of psoriasis vulgaris—Update Apremilast and Secukinumab—EDF in cooperation with EADV and IPC;A Nast;J Eur Acad Dermatology Venereol,2017

5. Consensus Guidelines for the Management of Plaque Psoriasis;S Hsu;Arch Dermatol,2012

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma proteins and inflammatory dermatoses: proteome-wide Mendelian randomization and colocalization analyses;Archives of Dermatological Research;2024-07-01

2. Burden of non-serious infections during biological use for rheumatoid arthritis;PLOS ONE;2024-02-20

3. The immunomodulatory effects of probiotics and azithromycin in dextran sodium sulfate-induced ulcerative colitis in rats via TLR4-NF-κB and p38-MAPK pathway;Biomedicine & Pharmacotherapy;2023-09

4. Mutability of druggable kinases and pro-inflammatory cytokines by their proximity to telomeres and A+T content;PLOS ONE;2023-04-27

5. Management of patients with inflammatory rheumatic diseases after treatment failure with a first tumour necrosis factor inhibitor: A narrative review;Modern Rheumatology;2023-04-06